Double Dose of Tamiflu Offers No Added Benefit in Severe Flu

News   Jun 04, 2013

 
Double Dose of Tamiflu Offers No Added Benefit in Severe Flu
 
 
 

RELATED ARTICLES

Single-Dose Vaccine Could Provide Faster Protection in Cholera Epidemics

News

Each year there are more than three million cases of cholera worldwide, a disease transmitted through contaminated food and water that hits developing countries particularly hard. While the standard regimen for protecting against cholera with existing non-living oral cholera vaccines includes administering two doses over a two-week period, research now shows that giving a stronger single-dose of a live oral vaccine could be an effective tool in controlling outbreaks more quickly.

READ MORE

Severity of Autoimmune Disease Influenced by Time of Day

News

Insights into how the body clock and time of day influence immune responses are revealed today. Understanding the effect of the interplay between 24-hour day-night cycles and the immune system may help inform drug-targeting strategies to alleviate autoimmune disease.

READ MORE

Agent Reverses Resistance to Targeted Drug in Some Leukemias

News

After discovering how some hematologic cancer cells manage to elude death from a targeted therapy, Dana-Farber Cancer Institute scientists have double-crossed the cancer cells with a drug that renders them vulnerable to the targeted agent.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE